Home Health Law A Distinction of Opinion is Not a Misrepresentation

A Distinction of Opinion is Not a Misrepresentation

A Distinction of Opinion is Not a Misrepresentation


Photo of Michelle Yeary

So says the Fifth Circuit in Torrey v. Infectious Illnesses Society of America, — F.4th –, 2023 WL 7890067 (5th Cir. Nov. 16, 2023).  Which joins the Second and Third Circuits in defending scientific free speech.  Instances we mentioned right here and right here and which assist our agency perception that scientific articles are “core” speech that’s absolutely protected below the First Modification. 

Torrey in not a merchandise legal responsibility case.  Plaintiffs, people who allege they undergo from persistent Lyme illness signs, introduced a misrepresentation declare towards the Infectious Illnesses Society of American (“IDSA”) concerning pointers IDSA printed in a peer-reviewed medical journal.  Plaintiffs declare the rules forged doubt on how continual Lyme illness needs to be handled and even whether or not the situation exists.  Plaintiffs allege this led to insurance coverage corporations denying protection for continual Lyme illness.  Id. at *1. 

Why are we ?  As a result of this isn’t to date off from the assaults on scientific speech that we see in merchandise legal responsibility litigation.  Assaults on methodology used.  Assaults on potential conflicts of curiosity resulting from company funding.  The forms of assaults that needs to be resolved by the scientific neighborhood, not litigation.  So, we laud choices no matter context that assist our view that no person ought to be capable of use litigation to sue the opposite aspect of an ongoing scientific debate into silence.

The district court docket in Torrey dismissed the misrepresentation declare as a result of “medical opinions” are “not factual representations.”  Id. at *2.  The truth that different research exist that attain totally different conclusions doesn’t make the IDSA pointers factual misrepresentations.  On attraction, the Fifth Circuit reviewed the choice de novo. 

First, the court docket discovered that plaintiffs didn’t problem the premise that “merely publishing a medical opinion,” can not give rise to legal responsibility for misrepresentation.  Id. at *3.  Relatively, plaintiffs claimed that the district court docket didn’t learn the rules “in context.”  Plaintiffs prompt that the check needs to be “the notion” of the rules as utilized by the medical neighborhood however cited no authority for that proposition.  The court docket in truth regarded on the pointers as an entire, discovering they’re explanations of medical analysis and data citing to different printed research and scientific trials.  Versus plaintiffs who focused “remoted parts” of the rules.  Id.

Second, plaintiffs argued that the rules “clarify away” contradictory research.  However that’s a part of the scientific course of – analyzing and refuting contradictory proof.  Scientific literature does “not grow to be actionable factual representations merely as a result of [it] disapprove[s] of research Plaintiffs favor.”  Id.  A distinction of opinion is jut that and nothing extra.

Third, plaintiffs argued that the rules disclaimer contradicts its opening sentence.  The opening sentence states that the rules are to be used by well being care suppliers who deal with Lyme illness.  The disclaimer primarily says the rules are simply that—pointers.  They “can not all the time account for particular person variation amongst sufferers” and supreme therapy choices needs to be made by the treating doctor.  Id. at *4.  Because the court docket famous, it’s hardly contradictory each to supply normal steering and to acknowledge that last therapy choices needs to be left to the judgment of the treating physician; the one that greatest is aware of the person affected person.

Lastly, plaintiffs targeted on two statements within the pointers which the court docket rapidly concluded had been medical opinions:

On this context (a scientific debate over therapy choices for persistent Lyme signs), to say that proof will not be “convincing” or that some therapy is “not advisable” is plainly to precise a medical opinion. Simply because Plaintiffs disagree with these opinions doesn’t imply that IDSA is by some means liable as a result of their medical doctors or insurance coverage suppliers discovered the opinions persuasive.


With completely no compelling argument from plaintiffs, the Fifth Circuit joined the others in holding that scientific discourse and journal articles are protected by the First Modification.  Ring one other bell for freedom of speech.



Please enter your comment!
Please enter your name here